The way SARS-CoV-2 mutates in immunocompromised patients to escape Paxlovid could help chemists design better drugs that are more difficult for the virus to sidestep.
Columbia researchers have found why babies are susceptible to repeated bouts of common respiratory infections—but also have a unique weapon to fight off new pathogens that healthy adults lack.
Patients with mpox who were treated with the antiviral drug tecovirimat had similar outcomes regardless of HIV status, find researchers at Columbia University and Weill Cornell Medicine.
On March 28, world leaders and global health experts will gather for Columbia University’s second annual Virtual Symposium on Vaccines and Global Health.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Columbia has helped launch New York City’s new Pandemic Response Institute, which will develop an equitable crisis response that doesn’t leave people behind.
Computer models have helped anticipate COVID’s peaks and troughs, but models have a “cone of uncertainty” and much about the future of the pandemic remains unknown.
Telemedicine as a way to deliver health care is here to stay. Columbia physicians are working together with members of the engineering and business schools to advance implementation of telemedicine.
What was learned by researchers during the pandemic has changed the mindset for scientists: “Why do we have to follow the old routine when we see a new paradigm working so well?”
Children were spared the worst of COVID-19 early on, but they are now suffering psychological consequences from the pandemic’s social upheaval. Here’s what parents and educators can do.